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Abstract
Sporadically, HAdVs from species HAdV-C are detected in acute respiratory disease outbreaks. To rapidly type these viruses,
we designed real-time PCR assays that detect and discriminate between adenovirus types HAdV-C1, -C2, -C5, and -C6.
Sixteen clinical isolates from the California Department of Public Health were used to validate the new assays. Type-specific
TaqMan real-time PCR assays were designed and used independently to successfully identify 16 representative specimens.
The lower limit of detection for our LightCycler singleplex real-time PCR assays were calculated to be 100, 100, 100, and 50
genomic copies per reaction for HAdV-C1, HAdV-C2, HAdV-C5 and HAdV-C6, respectively. The results for the singleplex
J.B.A.I.D.S. assays were similar. Our assays did not cross-react with other adenoviruses outside of species HAdV-C, respiratory
syncytial virus, influenza, or respiratory disease causing bacteria. These assays have the potential to be useful as diagnostic
tools for species HAdV-C infection.
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Introduction
Human adenoviruses (HAdVs) were the first respiratory viruses
to be isolated and characterized. Epidemiological studies show that
adenoviruses are a common cause of epidemic respiratory illness in
crowded adult populations [1,2]. Human adenoviruses are
members of the genus Mastadenovirus and are grouped into seven
species (A–G), based on their nucleic acid characteristics, penton,
hexon, and fiber protein characteristics, biological properties and
phylogenetic analysis [3,4,5,6,7]. They are associated with a broad
range of symptoms, including acute respiratory disease (ARD),
gastroenteritis, keratoconjunctivitis, and genitourinary infections
[1,2].
Viruses in species HAdV-C are weakly pathogenic in adult
populations [8]. In contrast, when they infect children under 2
years of age, the clinical outcome can lead to acute respiratory
disease, intussusception [9,10], pneumonia, or myocarditis in
infants under age 1 [11–12]. Moreover, an association between
prenatal species HAdV-C infection and development of childhood
acute leukemia was recently reported [13].
In the previous century, HAdVs were detected by tissue culture
and discriminated by type-specific serum neutralization methods
[14]. However, traditional (probeless) PCR assays have since
replaced these methods owing to their greater speed, significantly
lower cost, and to the decline in availability of type-specific
antisera [15]. A variety of reliable PCR assays have been
developed and used, including species-specific [16] and type-
specific [17] tests. Universal PCR assays paired with sequence
analysis has been used to provide a truly comprehensive detection
and discrimination method for all HAdV types [18]. Real-time
(probe-based) PCR platforms now offer even greater efficiency,
improved sensitivity and specificity, and the added information
value resulting from quantitative analysis of viral titers [19,20,21].
In this study we developed a series of real-time PCR assays for
both the LightCycler and the military Joint Biological Agent
Identification Detection System (J.B.A.I.D.S.) platforms which can
detect and discriminate between HAdVs in species HAdV-C.
Combined, these tools offer a rapid, high-throughput method for
detection and discrimination of viruses in species HAdV-C. These
assays will allow for much more rapid outbreak assessment, and, if
validated as in-house diagnostic assays, more rapid individual and
public health responses.
Results
LightCycler and J.B.A.I.D.S. TaqMan real-time PCR assays
The detection of Human adenoviruses C1 (HAdV-C1), -C2,
-C5, and –C6 by real-time PCR from cultured isolates is
summarized in Table 1. All samples were tested on the
LightCycler 2.0 and the J.B.A.I.D.S platforms. All positive samples
were correctly identified (Table 1).
Lower limit of detection for singleplex assays
Standard curves were created using different dilutions of
genomic DNA ranging from 50 to 10
7 genome copies per assay
from each HAdV (Fig. 1). Using the LightCycler 2.0, the lower
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100, and 50 genomic copies per reaction for HAdV-C1, -C2, -C5,
and –C6, respectively (Table 2). Using the J.B.A.I.D.S. the LLOD
for our singleplex assays was 50, 50, 100, and 100 genomic copies
per reaction for HAdV-C1, -C2, -C5, and –C6, respectively
(Table 2). We defined the LLOD as the last dilution before the
crossing points stopped increasing. The singleplex assay results for
HAdV-C1, -C2, -C5, and –C6 were similar on the J.B.A.I.D.S.
system (Table 2). Linear regression of the CP values and the
quantity of genomic DNA revealed negative linearity for all curves
(Fig. 1), corresponding to 100, 97, 93, and 99% PCR efficiency for
HAdV-C1, -C2, -C5, and –C6 singleplex assays, respectively. The
dynamic range for the HAdV-C2 and –C6 assays was 50 to
1.0610
7 DNA genomic copies per PCR reaction and 10
2 to
1.0610
6 DNA genomic copies per PCR reaction for HAdV-C1
and HAdV-C5. These experiments were repeated twice with
similar results.
Specificity of Real-Time PCR assays
Because adenoviruses in species HAdV-C are well conserved in
the hexon and fiber genes, we wanted to determine if our assays
were specific to the target HAdV types. Analytical specificity data
is shown in Table 3. Assays that detect HAdV-C2, -C5, and –C6
showed low level amplification with HAdV-C1, -C2, and –C5,
respectively after 35 cycles. However, our assays did not react with
HAdV-B3, -E4, -B7, -B11, -B14, or –B21. In addition, our real-
time PCR assays did not generate false positive results when
challenged with genomic DNA extracted from other agents which
cause respiratory disease such as Haemophilus influenza, Influenza A
virus, Human rhinovirus, Human parainfluenza virus, Human respiratory
syncytial virus, Chlamydophila pneumonia, Escherichia Coli, Klebsiella
pneumonia, Pseudomonas aeruginosa, Mycoplasma pneumonia, and Legion-
ella Pneumophila.
Discussion
There has been a need for a rapid, accurate diagnostic type
specific assays which are able to differentiate HAdVs. Currently
there are type specific real-time PCR assays for species HAdV-B
and HAdV-E [20,21], but not for species HAdV-C. Since viruses
in species HAdV-C cause morbidity in people who are
immunosupressed and/or immunocompromised [22,23], it is
critical to be able to detect and discriminate between all common
respiratory HAdV types. We describe the first series of real-time
PCR assays which can discriminate between the four viruses which
are known in species HAdV-C.
Table 1. Summary of Human adenovirus (HAdV) detection by real-time PCR using the LightCycler 2.0 and J.B.A.I.D.S. in cultured
isolates from the CDPH.
Samples LightCycler 2.0 real-time PCR J.B.A.I.D.S. real-time PCR
Positive Negative Positive Negative
HAdV-C1 6 0 6 0
HAdV-C2 4 0 4 0
HAdV-C5 5 0 5 0
HAdV-C6 1 0 1 0
doi:10.1371/journal.pone.0026862.t001
Figure 1. Standard curves for amplification of HAdV-C1, -C2, -C5, and -C6. Detection by real-time LightCycler PCR in a series of dilutions of
genomic HAdV-C1, -C2, -C5, and -C6 DNA. Linear regression of the standard curves for (A) HAdV- C1, (B) HAdV-C2, (C) HAdV-C5, and (D) HAdV-C6. We
defined the LLOD as the last dilution before the crossing points ceased to increase.
doi:10.1371/journal.pone.0026862.g001
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HAdV-B14 outbreak in 2006 [24,25], it is important to have high-
quality assays readily available that can determine which
adenovirus is present. Although the described singleplex assays
can be used to determine whether or not nucleic acid from a virus
in species HAdV-C is present in less than two hours, which is faster
than conventional PCR, we recommend that these assays be used
on isolates that are untypeable via PCR assays that have been
validated for clinical samples [21].
In terms of cost, the described real-time PCR assays are less
labor intensive which directly decreases the cost of testing each
sample. Moreover, the cost of the primers and probes is less than a
dollar per test. Thus, our assays are rapid and inexpensive.
One limitation to the described assays is that they target the
hexon gene which has been shown to be incomplete when typing
HAdVs [3]. If a HAdV which has the fiber of HAdV-C1 and the
hexon of HAdV-C5, using the singleplex assays described in this
study, the virus would be incorrectly typed as HAdV-C5.
However, if these assays are used on a sample that contains two
viruses from species HAdV-C, both viruses will be detected in
separate capillaries.
The described singleplex assays were able to accurately detect
the four known viruses in species HAdV-C. Unfortunately, after
35 cycles the primer/probe pairs for HAdV-C2, -C5, and –C6
amplified low levels of HAdV-C1, -C2, and –C5, respectively.
This may be due to the fact that the viruses in species HAdV-C are
genetically similar [26]. However, this was surprising in light of the
genetic diversity that is present in the hexon genes of the viruses in
species HAdV-C (Fig. 2). This was the region we used to design all
primer/probe pairs. This demonstrates the complexity of
designing type-specific assays using real-time PCR.
Conclusions
We generated single real-time PCR assays that are sensitive and
specific and provide accurate quantitation of HAdV in species
HAdV-C. These assays have the potential to be useful as routine
diagnostic tools for the rapid detection of clinical samples on
already existing platforms which are positive for HAdV-C1, -C2,
-C5, and –C6.
Materials and Methods
Ethics Statement
The work reported herein was approved by the Institutional
Review Board at the David Grant USAF Medical Center.
Informed Consent was not required, because we did not use
clinical samples.
Viral Isolates
Samples collected at CDPH were clinical isolates cultured in
A549 cells, and subsequently frozen at 280uC and transported on
dry ice for testing. Aliquots used in this study were subjected to one
freeze/thaw cycle in the process of aliquotting upon receipt at
CDPH, and one further freeze/thaw cycle when aliquotted for
shipment to the David Grant Medical Center. The A549 cells used
in this study were used in a previous study [5,20] and are a
common cell line used for adenovirus research.
Processing of cultured viruses for PCR
Cultured isolates were processed as follows. Nucleic acid was
extracted from 175 mL aliquots using the MagNA Pure LC DNA
Isolation Kit I (Roche, Indianapolis, IN, USA) according to the
manufacturers’ recommendations for the MagNA Pure LC
automated nucleic acid extraction system. Adenovirus strains
HAdV-B14 (VR-15), -B3 (VR-3), -E4 (VR-1572), -B7 (VR-7),
-B11 (VR-12), -B21 (VR-256), Haemophilus influenza, Influenza
A virus (ATCC VR-96), Human rhinovirus 14 (ATCC VR-284),
Human parainfluenza virus 2 (ATCC VR-92), Human respiratory
syncytial virus (ATCC VR-26), Chlamydophila pneumonia (ATCC
53592), Escherichia Coli, Klebsiella pneumonia (ATCC 13883),
Pseudomonas aeruginosa (ATCC 97), Mycoplasma pneumonia, and
Legionella Pneumophila (ATCC 33152) were acquired from the
American Type Culture Collection (ATCC; Manassas, VA, USA).
Genomic DNA from each adenovirus strain was quanitated by
Table 3. Specificity table of each HAdV assay.
Pathogen HAdV-C1 HAdV-C2 HAdV-C5 HAdV-C6
HAdV-C1 + a
HAdV-C2 + b
HAdV-C5 + c
HAdV-C6 +
HAdV-B3
HAdV-E4
HAdV-B7
HAdV-B11
HAdV-B14
HAdV-B21
Haemophilus influenzae
Influenza A virus
Human rhinovirus
Human parainfluenza virus
Human respiratory
syncytial virus
Chlamydophila
pneumoniae
Escherichia Coli
Klebsiella pneumonia
Pseudomonas aeruginosa
Mycoplasma pneumoniae
Legionella Pneumophila
a – Low levels of HAdV-C1 was detected with the HAdV-C2 primers and probes
after 35 cycles.
b – Low levels of HAdV-C2 was detected with the HAdV-C5 primers and probes
after 35 cycles.
c – Low levels of HAdV-C5 was detected with the HAdV-C6 primers and probes
after 35 cycles.
doi:10.1371/journal.pone.0026862.t003
Table 2. LLOD for HAdV singleplex reactions (genome
copies/reaction).
LLOD LightCycler 2.0 LLOD J.B.A.I.D.S.
HAdV-C1 100 50
HAdV-C2 100 50
HAdV-C5 100 100
HAdV-C6 50 100
doi:10.1371/journal.pone.0026862.t002
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the NanaDrop 8000 (Thermo Scientific, Wilmington).
Optimization of assays
First, we performed experiments to determine the appropriate
annealing temperature for each series of primers via conventional
PCR. Reaction conditions were as follows: initial denaturation at
95uC for 15 min, followed by 40 cycles of denaturation at 95uC for
15 s, annealing temperature gradient ranged from 48uCt o6 5 uC
for 30 s, and extension at 72uC for 30 s. Each singleplex assay was
optimized for MgCl2 concentration as well as extension and
annealing times. To optimize the MgCl2 concentration, we used 0,
1, 2, 3, 4, 5 and 6 mM MgCl2 as the final concentration of the
PCR reaction. We also amplified a fixed amount of genomic DNA
with different annealing (25, 20, and 15s) and extension times (20,
15, 10, and 5s). The FastStart High Fidelity PCR System kit was
used for all conventional PCR (Roche).
Quantitative real-time PCR
The primers used to detect the different viruses in species HAdV-
C are listed in Table 4. Experiments were performed on a Joint
Biological Agent Identification and Diagnostic System (J.B.A.I.D.S)
and the LightCycler 2.0 (Roche). All J.B.A.I.D.S. experiments were
performed using the same primers, probes, and conditions as the
LightCycler 2.0. The J.B.A.I.D.S. thermocycler was conceived and
developed to rapidly identify biological warfare agents and other
pathogens of concern for the U.S. Military. For real-time
J.B.A.I.D.S. PCR, cycling was carried out in a J.B.A.I.D.S. real-
time thermocycler (Idaho Technologies, UT, USA) using 1 mlo f
extracted DNAin2 mlsofLCFastStart DNA MasterHybProbe mix
(Roche, Indianapolis, IN, USA) (Roche), containing 5 mM MgCl2
and 400 nM forward and reverse primers. Reaction conditions were
as follows: initial denaturation at 95uC for 15 min, followed by 45
cycles of denaturation at 95uCf o r1s ,a n n e a l i n ga t6 0 uC for 15 s,
and extension at 72uC for 5 s. The progress of real-time fluorescent
PCR was monitored at 530 nm. To establish external standard
curves for the quantification of each HAdV, genomic DNA from
each strain was diluted in a 10-fold series (10
2 to 10
7 copies per
reaction) and analyzed with the new assay. The samples that defined
the standard curve were performed in triplicate and repeated twice.
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